Amount Raised
$5 Million
Round Type
Series A
Plymouth MeetingBiotechnologyHealth CareScience And EngineeringInvestors
Description
Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced that it has secured $5 million in its Series A3 round. This financing adds 3B Future Health Fund (3B FHF) to Geneos' investor syndicate. Further, Dr. Roberto DePonti, managing director and general partner of 3B FHF, joins Geneos as a board observer, adding decades of pharmaceutical drug development experience to the company.
Quick answer
Geneos Therapeutics raised $5 Million in a Series A round, dated April 12, 2023. Investors: Dr. Roberto De Ponti. Geneos Therapeutics is based in Plymouth Meeting, Pennsylvania, United States.
- How much did Geneos Therapeutics raise?
- Geneos Therapeutics raised $5 Million in a Series A round on April 12, 2023.
- Who invested in Geneos Therapeutics?
- Dr. Roberto De Ponti is named as investors in this round.
- What does Geneos Therapeutics do?
- Geneos Therapeutics, a privately held, clinical stage biotherapeutics company, believes that the company's personalized therapeutic cancer vaccines (PTCVs) may serve an important role in new immunotherapeutic paradigms..
- Where is Geneos Therapeutics based and how big is it?
- Geneos Therapeutics is based in Plymouth Meeting, Pennsylvania, United States.
- Who are the decision-makers at Geneos Therapeutics?
- Fundz holds 2 contacts at Geneos Therapeutics, including the Vice President Head Of Operations Business Development. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Geneos Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Ray Therapeutics raised $14M on May 15, 2023.
- Wheeler Bio raised $31M (Series A) on April 13, 2023.
- 22nd Century raised $21M (Debt Financing) on March 3, 2023.
- Aprea Therapeutics raised an undisclosed amount (Funding Round) on February 28, 2023.
- Conformal Medical raised $35M on May 26, 2023.
- Qnovia raised $2.9M on May 25, 2023.
Who to call at Geneos Therapeutics, and when
A new round usually means Geneos Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Geneos Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Geneos Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Geneos Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Geneos Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGeneos Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.